FDA.reportPublic FDA data

5 ML viltolarsen 50 MG/ML Injection

RxCUI
2389844
RxNorm name
5 ML viltolarsen 50 MG/ML Injection
Display name
5 ML viltolarsen 50 MG/ML Injection
Full name
5 ML viltolarsen 50 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ViltepsoVILTOLARSENNS Pharma, Inc.1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d1232025-07-16Warnings, Adverse reactionsExact identifier
rxcui: 2389844

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123viltolarsen 250 MG in 5 ML Injection [PSN] · 5 ML viltolarsen 50 MG/ML Injection [SCD] · viltolarsen 250 MG per 5 ML Injection [SY]37These highlights do not include all the information needed to use VILTEPSO ® safely and effectively. See full prescribing information for VILTEPSO. VILTEPSO (viltolarsen) injection, for intravenous use Initial U.S. Approval: 202020250716